Yoni Freedhoff on Muck Rack

Yoni Freedhoff

Ottawa
As seen in: Medscape, Elemental, Medium, The New York Times, Color Research & Application, TIME, Yahoo News, Psychology Today, The Globe and Mail, U.S. News and World Report, Vox and
Associate Professor of Family Medicine/Not Your Good Jew/עם ישראל חי
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yoni

Contact Yoni, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pérdida muscular con agonistas del receptor del péptido 1 similar al glucagón: ¿alarma real o controversia fabricada?

|
By Yoni Freedhoff
| Medscape Noticias Médicas Verified
Es muy probable que haya escuchado que los fármacos agonistas del receptor del péptido 1 similar al glucagón (GLP-1) provocan pérdida de tejido magro (músculo). Probablemente haya leído historias alarmistas al respecto o visto publicaciones en redes sociales que difunden el catastrofismo. Y si eso le preocupa, felicidades: también ha sido víctima de una controversia fabricada. Llegaremos a los datos en un momento, pero primero un experimento mental sencillo.
Open in Who Shared Issue with article?

Even Physicians’ Insurance Plans Don’t Cover GLP-1s for Obesity

|
By Yoni Freedhoff
| Medscape Verified
Recent US estimates see only 19% of companies with 200+ workers covering GLP-1s for weight loss in their largest plan, rising to 43% among firms with 5,000+ workers. It seems surprising, especially since GLP-1s are among the most important new medication classes of our lifetimes, showing that, for many, obesity, a disease known to shorten both quantity and quality of life, may be remissible.
Open in Who Shared Issue with article?

Obesity Is Finally a Choice, Just Not Like You Imagined

|
By Yoni Freedhoff
| Medscape Verified
The past century or so’s zeitgeist about obesity being a personal choice is finally being vindicated, but no, not consequent to lifestyle change working because people wanted it badly enough. The sad truth is that lifestyle change alone has never been enough. In fact, not even one of the actual thousands of lifestyle intervention studies conducted over the past 100-plus years has demonstrated a scalable, reproducible approach leading to durable, clinically meaningful weight loss.
Open in Who Shared Issue with article?
See all 568 licensed articles (569 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified